Real-time enrollment status for this ogvhd clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:45 AM UTC
| NCT Number | NCT07776210 |
| Recruiting Status | Recruiting |
| Condition | oGVHD |
| Phase | PHASE3 |
| Target Enrollment | 30 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Regenerative Ocular Immunobiologics LLC |
| Last Updated on CT.gov | September 4, 2026 (Sep 4, 2026) |
As of October 16, 2026: Clinical trial NCT07776210 is currently recruiting participants. This phase3 study for ogvhd is actively seeking new participants at 5 locations across the United States. The study is sponsored by Regenerative Ocular Immunobiologics LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07776210 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07776210 was last updated Sep 4, 2026 (September 4, 2026). HelloStudys verifies this status automatically.